AskNiveshClosed·19:41 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs
  • Earnings

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Currency Rates
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to TORNTPHARM

Torrent Pharmaceuticals Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsSep-24Dec-24Mar-25Jun-25Sep-25Dec-25Mar-26Jun-26
Revenue
2,8892,8092,9593,1783,3023,3034,1974,921
Other income
-1633-18-37-27-13-17-12
Expenses
2,2122,1512,2522,4032,4712,4663,5854,155
Cost of materials consumed
337370402396382414566609
Purchases of stock-in-trade
382420416338382422477531
Change in inventories
-41-117-874036-37-2823
Employee benefit expense
543549561605627651788893
Finance costs
645756564845236305
Depreciation & amortisation
198199201201204206508593
Other expenses
7296737037677927651,0381,201
EBITDA
9239479229951,0431,0651,2731,631
EBIT
7257487217948398597651,038
Exceptional items
---24--13-10-66-21
Profit Before Tax
661691665738791814529733
Tax expense
208188167190200179165167
Deferred tax
5235-17-11-33-65-1-87
Net Profit
453503498548591635364566
Financial Ratios
Operating Profit Margin
25.10%26.63%24.37%24.98%25.41%26.01%18.23%21.09%
EBITDA Margin
31.95%33.71%31.16%31.31%31.59%32.24%30.33%33.14%
Net Profit Margin
15.68%17.91%16.83%17.24%17.90%19.22%8.67%11.50%
Earnings Per Share (₹)
13.3714.8814.7116.1917.4518.7711.5114.87

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.